Healthcare stocks were edging higher premarket Wednesday, with the State Street Health Care Select Sector SPDR ETF (XLV) up 0.3% and the iShares Biotechnology ETF (IBB) advancing by 0.6%.
Roivant Sciences (ROIV) stock was up more than 8% after the company reported that it swung to a fiscal Q4 net income.